What is it about?
In a prospective cohort study of nearly 150 older survivors of acute respiratory failure, we show that higher serum GDF-15 is independently associated with weaker diaphragm, limb, and hand grip strength during the week prior to hospital discharge, and lower rates of ADL recovery over 6-month follow-up. Our findings support further study of GDF-15 as a potential serum biomarker of skeletal muscle mitochondrial function in ICU survivors that may be valuable as a predictive or prognostic enrichment tool in early phase trials of post-ICU rehabilitation or novel therapies aimed at improving post-ICU disability.
Featured Image
Read the Original
This page is a summary of: Growth differentiation factor-15 as a biomarker of strength and recovery in survivors of acute respiratory failure, Thorax, September 2019, BMJ,
DOI: 10.1136/thoraxjnl-2019-213621.
You can read the full text:
Contributors
The following have contributed to this page